x
Filter:
Filters applied
- Congenital: Fontan
- Cordina, RachaelRemove Cordina, Rachael filter
Publication Date
Please choose a date range between 2020 and 2021.
Congenital: Fontan
2 Results
- Congenital: Fontan
Long-term outcomes of warfarin versus aspirin after Fontan surgery
The Journal of Thoracic and Cardiovascular SurgeryVol. 162Issue 4p1218–1228.e3Published online: January 4, 2021- Chantal Attard
- Paul T. Monagle
- Yves d'Udekem
- Mark T. Mackay
- Julie Briody
- Rachael Cordina
- and others
Cited in Scopus: 11Because of the nature of the Fontan physiology, patients are at an increased risk of thromboembolic complications. As such, warfarin or aspirin is generally prescribed lifelong for thromboprophylaxis. This study aimed to compare long-term rates of cerebrovascular injury, thrombosis, bleeding, bone mineral density, and quality of life in people living with Fontan circulation receiving warfarin compared with aspirin. - Congenital: Fontan
Protein-losing enteropathy and plastic bronchitis after the Fontan procedure
The Journal of Thoracic and Cardiovascular SurgeryVol. 161Issue 6p2158–2165.e4Published online: August 11, 2020- Varun J. Sharma
- Ajay J. Iyengar
- Diana Zannino
- Thomas Gentles
- Robert Justo
- David S. Celermajer
- and others
Cited in Scopus: 15Protein losing enteropathy and plastic bronchitis are severe complications in Fontan circulation, with 5-year survival ranging from 46% to 88%. We report risk factors and outcomes of protein losing enteropathy and plastic bronchitis in patients undergoing the Fontan.